 | |
| Clinical data | |
|---|---|
| Other names | 4-Isothiocyanato-PCP |
| Drug class | Irreversible dopamine transporter blocker; Reversible NMDA receptor antagonist; Psychostimulant antagonist |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H24N2S |
| Molar mass | 300.46 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Fourphit, also known as 4-isothiocyanato-PCP, is an irreversible dopamine transporter (DAT) blocker and a reversible NMDA receptor antagonist. It blocks the binding of methylphenidate to the DAT in vitro, though apparently not in vivo. In any case, the drug reduces the stimulant-like effects of cocaine in animals, whilst producing mostly negligible behavioral effects itself. Fourphit is an acylating derivative of phencyclidine (PCP) and a positional isomer of metaphit (3-isothiocyanato-PCP).
See also
References
- ^ Schweri MM, Thurkauf A, Mattson MV, Rice KC (June 1992). "Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter". J Pharmacol Exp Ther. 261 (3): 936–942. PMID 1602399.
- ^ Schweri MM, de Costa BR, Rice KC (July 1998). "Fourphit, an acylating phencyclidine derivative, attenuates cocaine-induced hyperactivity in rats". Pharmacol Biochem Behav. 60 (3): 615–623. doi:10.1016/s0091-3057(98)00040-9. PMID 9678644.
| Ionotropic glutamate receptor modulators | |
|---|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
| KARTooltip Kainate receptor |
|
| NMDARTooltip N-Methyl-D-aspartate receptor |
|
 | This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |